Clinical Trial Update: ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for ALY688 ophthalmic solution in dry eye disease across Phase 2 and Phase 3 shows completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• ALY688

Snippet

Sponsor: Allysta Pharmaceutical | Conditions: Dry Eye | Phase 2, Phase 3 | Status: COMPLETED